AIkido Pharma (AIKI) Competitors $1.26 -0.05 (-3.89%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends AIKI vs. ONMD, BIAF, ISPC, IQV, ICLR, INCY, MEDP, CRL, OABI, and NRCShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include OneMedNet (ONMD), bioAffinity Technologies (BIAF), iSpecimen (ISPC), IQVIA (IQV), ICON Public (ICLR), Incyte (INCY), Medpace (MEDP), Charles River Laboratories International (CRL), OmniAb (OABI), and National Research (NRC). These companies are all part of the "commercial physical research" industry. AIkido Pharma vs. OneMedNet bioAffinity Technologies iSpecimen IQVIA ICON Public Incyte Medpace Charles River Laboratories International OmniAb National Research OneMedNet (NASDAQ:ONMD) and AIkido Pharma (NASDAQ:AIKI) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership. Which has more volatility & risk, ONMD or AIKI? OneMedNet has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, AIkido Pharma has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Is ONMD or AIKI more profitable? OneMedNet's return on equity of 0.00% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets OneMedNetN/A N/A -222.16% AIkido Pharma N/A -18.21%-16.94% Does the media refer more to ONMD or AIKI? In the previous week, OneMedNet had 1 more articles in the media than AIkido Pharma. MarketBeat recorded 1 mentions for OneMedNet and 0 mentions for AIkido Pharma. OneMedNet's average media sentiment score of 1.38 beat AIkido Pharma's score of 0.00 indicating that OneMedNet is being referred to more favorably in the media. Company Overall Sentiment OneMedNet Positive AIkido Pharma Neutral Which has preferable valuation and earnings, ONMD or AIKI? AIkido Pharma has lower revenue, but higher earnings than OneMedNet. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOneMedNet$1.14M34.32-$33.78MN/AN/AAIkido Pharma$10K691.11-$7.17M-$3.88-0.32 Does the MarketBeat Community believe in ONMD or AIKI? AIkido Pharma received 101 more outperform votes than OneMedNet when rated by MarketBeat users. CompanyUnderperformOutperformOneMedNetN/AN/AAIkido PharmaOutperform Votes10163.92% Underperform Votes5736.08% Do institutionals & insiders hold more shares of ONMD or AIKI? 0.9% of OneMedNet shares are owned by institutional investors. Comparatively, 10.9% of AIkido Pharma shares are owned by institutional investors. 44.7% of OneMedNet shares are owned by insiders. Comparatively, 8.6% of AIkido Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryAIkido Pharma beats OneMedNet on 6 of the 11 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.91M$4.20B$5.14B$9.08BDividend YieldN/A1.78%5.09%4.23%P/E Ratio-0.3255.3490.0517.18Price / Sales691.1147.471,116.25117.05Price / CashN/A23.6243.1037.85Price / Book0.073.144.784.78Net Income-$7.17M$139.50M$120.31M$225.60M7 Day Performance-18.18%-0.35%-1.92%-1.23%1 Month Performance-22.70%1.31%13.65%0.46%1 Year Performance-40.28%11.28%28.34%15.24% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$1.26-3.9%N/A-38.5%$6.91M$10,000.00-0.324ONMDOneMedNetN/A$0.95+2.2%N/A+21.7%$26.70M$1.02M0.002Earnings ReportPositive NewsGap UpBIAFbioAffinity Technologies2.6952 of 5 stars$1.06+1.9%$6.00+466.0%-32.0%$16.53M$2.53M0.0010Gap UpISPCiSpecimen0.8734 of 5 stars$3.93+0.8%N/A+502.9%$3.77M$9.93M0.0060News CoverageIQVIQVIA4.9074 of 5 stars$208.41+2.9%$256.50+23.1%-14.0%$37.83B$14.98B26.5987,000Analyst ForecastICLRICON Public4.2227 of 5 stars$221.88+2.0%$292.45+31.8%-26.6%$18.31B$8.12B24.2441,100Analyst ForecastINCYIncyte4.7108 of 5 stars$75.92+1.3%$77.16+1.6%+11.6%$14.63B$3.70B542.322,524Analyst ForecastMEDPMedpace4.6196 of 5 stars$351.93+0.4%$380.56+8.1%+9.0%$10.94B$1.89B30.695,900CRLCharles River Laboratories International4.5336 of 5 stars$200.42+4.5%$214.38+7.0%-21.2%$10.25B$4.13B24.0121,800Positive NewsOABIOmniAb1.2687 of 5 stars$4.14+3.0%$9.00+117.4%-40.9%$584.65M$34.16M0.007NRCNational Research1.2218 of 5 stars$19.48+2.6%N/A-56.5%$457.39M$148.58M17.22435 Related Companies and Tools Related Companies OneMedNet Alternatives bioAffinity Technologies Alternatives iSpecimen Alternatives IQVIA Alternatives ICON Public Alternatives Incyte Alternatives Medpace Alternatives Charles River Laboratories International Alternatives OmniAb Alternatives National Research Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AIKI) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
